IVD Human

Isovaleryl Coenzyme A Dehydrogenase Human Recombinant
Cat. No.
BT10629
Source
Escherichia Coli.
Synonyms
FLJ12715, isovaleryl-CoA dehydrogenase mitochondrial, FLJ34849, EC 1.3.99.10, IVD, ACAD2.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

IVD Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 415 amino acids (33-426 a.a.) and having a molecular mass of 45.3 kDa.
The IVD is fused to a 20 amino acid his tag at N-terminus and purified by conventional chromatography.

Product Specs

Introduction
Isovaleryl-CoA dehydrogenase (IVD) is a mitochondrial enzyme involved in the breakdown of the amino acid leucine. Specifically, it catalyzes the third step in this pathway, converting isovaleryl-CoA to 3-methylcrotonyl-CoA. Deficiency in IVD prevents the normal breakdown of leucine, leading to a buildup of isovaleric acid in the body. This condition, known as isovaleric acidemia, can cause significant health problems due to the toxic effects of isovaleric acid on the nervous system. IVD is a homotetrameric enzyme, meaning it is composed of four identical subunits. Each subunit contains a flavin adenine dinucleotide (FAD) molecule, which is essential for its enzymatic activity.
Description
This product consists of the human IVD enzyme, produced recombinantly in E. coli bacteria. It is engineered without any glycosylation (addition of sugar molecules) and exists as a single polypeptide chain of 415 amino acids. This includes amino acids 33 to 426 of the native human IVD protein, along with an additional 20 amino acid histidine tag at the N-terminus to facilitate purification. The purified protein has a molecular weight of approximately 45.3 kDa.
Physical Appearance
Clear and colorless liquid, sterilized by filtration.
Formulation
The IVD protein is supplied in a solution at a concentration of 1 mg/ml. The solution is buffered with 20mM Tris-HCl at pH 8 and contains 1mM DTT to prevent protein degradation, and 10% glycerol to enhance stability.
Stability
For short-term storage (up to 4 weeks), keep the vial refrigerated at 4°C. For longer storage, freeze the product at -20°C. Adding a carrier protein like albumin (HSA or BSA) to a final concentration of 0.1% is recommended for long-term storage. Avoid repeated freezing and thawing of the protein solution.
Purity
The purity of the IVD protein is greater than 90%, as determined by SDS-PAGE analysis.
Synonyms
FLJ12715, isovaleryl-CoA dehydrogenase mitochondrial, FLJ34849, EC 1.3.99.10, IVD, ACAD2.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MHSLLPVDDA INGLSEEQRQ LRQTMAKFLQ EHLAPKAQEI DRSNEFKNLR EFWKQLGNLG VLGITAPVQY GGSGLGYLEH VLVMEEISRA SGAVGLSYGA HSNLCINQLV RNGNEAQKEK YLPKLISGEY IGALAMSEPN AGSDVVSMKL KAEKKGNHYI LNGNKFWITN GPDADVLIVY AKTDLAAVPA SRGITAFIVE KGMPGFSTSK KLDKLGMRGS NTCELIFEDC KIPAANILGH ENKGVYVLMS GLDLERLVLA GGPLGLMQAV LDHTIPYLHV REAFGQKIGH FQLMQGKMAD MYTRLMACRQ YVYNVAKACD EGHCTAKDCA GVILYSAECA TQVALDGIQC FGGNGYINDF PMGRFLRDAK LYEIGAGTSE VRRLVIGRAF NADFH.

Product Science Overview

Structure and Function

Isovaleryl Coenzyme A Dehydrogenase is encoded by the IVD gene located on chromosome 15 in humans . The enzyme is a member of the acyl-CoA dehydrogenase family, which is characterized by its ability to catalyze the dehydrogenation of acyl-CoA derivatives. The enzyme’s active site binds flavin adenine dinucleotide (FAD) as a cofactor, which is essential for its catalytic activity .

The primary function of IVD is to facilitate the breakdown of leucine, an essential amino acid, by catalyzing the conversion of isovaleryl-CoA to 3-methylcrotonyl-CoA. This reaction is a critical step in the leucine catabolic pathway, which ultimately leads to the production of acetyl-CoA and acetoacetate, molecules that can be utilized for energy production .

Genetic Deficiency and Associated Disorders

A deficiency in IVD activity due to mutations in the IVD gene results in a metabolic disorder known as isovaleric acidemia . This condition is characterized by the accumulation of isovaleric acid, a toxic compound that can lead to severe metabolic disturbances. Symptoms of isovaleric acidemia can range from mild to life-threatening and may include vomiting, lethargy, seizures, and a distinctive “sweaty feet” odor .

Isovaleric acidemia can present in two major clinical forms: an acute neonatal form and a chronic intermittent form. The acute form typically manifests shortly after birth with severe metabolic crises, while the chronic form presents later in life with intermittent episodes of metabolic decompensation .

Recombinant Production

The recombinant form of Isovaleryl Coenzyme A Dehydrogenase is produced using genetic engineering techniques. The IVD gene is cloned into an expression vector, which is then introduced into a suitable host organism, such as Escherichia coli or yeast. The host cells are cultured under conditions that promote the expression of the recombinant enzyme, which is subsequently purified using chromatographic techniques .

Recombinant IVD is used in various research applications, including studies on enzyme kinetics, structure-function relationships, and the development of therapeutic strategies for isovaleric acidemia. The availability of human recombinant IVD allows for detailed biochemical and biophysical analyses, which are essential for understanding the enzyme’s function and its role in metabolic disorders .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.